Next Investors logo grey

Shark Mitigation Systems successfully completes trials

Published 16-NOV-2016 16:14 P.M.


2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.

Click Here to View Latest Articles

Australian marine technology group, Shark Mitigation Systems (ASX: SM8) has successfully completed trials of its proprietary SAMS visual technology at Mossel Bay in South Africa.

In June 2016 comprehensive independent trials of the technology were commenced by the University of Western Australia Oceans Institute.

The trials were conducted within a known active population of white sharks, and with the benefit of observing several encounters the Institute was able to provide a statistically valid data set for robust scientific evaluation.

The independent analysis of the data was completed, and the results of the study scientifically validated the effectiveness of the technology as an effective deterrent in respect of mitigating the risk of shark attacks.

This is early stage technology and a young company, so investors should use this information in conjunction with all available company information and seek professional financial advice when considering this stock for their portfolio.

SM8 has developed a visual deterrent technology as well as a shark detection device, both of which are non-invasive and not harmful to sharks. It is the company’s intention to develop and commercialise these technologies, as well as establish a pipeline of further innovative marine technology.

Next Investors Image

Commenting on the completion of recent testing, SM8’s co-founder and director Craig Anderson said, “The results from this field study represent an exciting outcome and critical milestone for the company, and given that it now has scientific validation from a statistically valid field test, it proves this aspect of our technology is effective in reducing the risk of shark attack”.

Anderson highlighted that having identified new aspects of large predatory sharks’ visual systems, the company has been able to develop the disruptive SAMS technology coloration pattern which has delayed the time taken for a shark to engage by up to 400% on average in comparison to black neoprene.

Results viewed as compelling with practical applications by University of W.A.

Professor Shaun Collin of the Oceans Institute at the University of Western Australia described the outcome as compelling, particularly given that it can potentially make an impact on practical outcomes.

One of the interesting prospects on the horizon is the adoption of SM8’s technology at a commercial level with the possibility that its use may become mandatory under Occupational Health & Safety standards.

General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.